Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease

Kimberly N. Weaver; Xian Zhang; Xiangfeng Dai; Wenli Chen; Runa Watkins; Jeremy Adler; Marla C. Dubinsky; Arthur Kastl; Athos Bousvaros; Jennifer A. Strople; Raymond K. Cross; Peter D.R. Higgins; Ryan C. Ungaro; Meenakshi Bewtra; Emanuelle Bellaguarda; Francis A. Farraye; Riley Bs Craig; Cristian Hernandez; Margie E. Boccieri; Ann Firestine; Kelly Y. Chun; Millie D. Long; Michael D. Kappelman

doi:10.1093/ibd/izac138

Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease

Kimberly N. Weaver^*, Xian Zhang, Xiangfeng Dai, Wenli Chen, Runa Watkins, Jeremy Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A. Strople, Raymond K. Cross, Peter D.R. Higgins, Ryan C. Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A. Farraye, Riley Bs Craig, Cristian Hernandez, Margie E. Boccieri, Ann FirestineKelly Y. Chun, Millie D. Long, Michael D. Kappelman

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.

Original language	English (US)
Pages (from-to)	483-486
Number of pages	4
Journal	Inflammatory bowel diseases
Volume	29
Issue number	3
DOIs	https://doi.org/10.1093/ibd/izac138
State	Published - Mar 1 2023

Funding

This research was funded by the Leona M. and Harry B. Helmsley Charitable Trust. R.C.U. is funded by a National Institutes of Health Career Development Award (K23KD111995-01A1).

ASJC Scopus subject areas

Immunology and Allergy
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ibd/izac138

Cite this

Weaver, K. N., Zhang, X., Dai, X., Chen, W., Watkins, R., Adler, J., Dubinsky, M. C., Kastl, A., Bousvaros, A., Strople, J. A., Cross, R. K., Higgins, P. D. R., Ungaro, R. C., Bewtra, M., Bellaguarda, E., Farraye, F. A., Craig, R. B., Hernandez, C., Boccieri, M. E., ... Kappelman, M. D. (2023). Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 29(3), 483-486. https://doi.org/10.1093/ibd/izac138

@article{110d9129a3d544f9a5174b4d3d65a3f5,

title = "Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease",

abstract = "We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.",

author = "Weaver, {Kimberly N.} and Xian Zhang and Xiangfeng Dai and Wenli Chen and Runa Watkins and Jeremy Adler and Dubinsky, {Marla C.} and Arthur Kastl and Athos Bousvaros and Strople, {Jennifer A.} and Cross, {Raymond K.} and Higgins, {Peter D.R.} and Ungaro, {Ryan C.} and Meenakshi Bewtra and Emanuelle Bellaguarda and Farraye, {Francis A.} and Craig, {Riley Bs} and Cristian Hernandez and Boccieri, {Margie E.} and Ann Firestine and Chun, {Kelly Y.} and Long, {Millie D.} and Kappelman, {Michael D.}",

year = "2023",

month = mar,

day = "1",

doi = "10.1093/ibd/izac138",

language = "English (US)",

volume = "29",

pages = "483--486",

journal = "Inflammatory bowel diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "3",

}

Weaver, KN, Zhang, X, Dai, X, Chen, W, Watkins, R, Adler, J, Dubinsky, MC, Kastl, A, Bousvaros, A, Strople, JA, Cross, RK, Higgins, PDR, Ungaro, RC, Bewtra, M, Bellaguarda, E, Farraye, FA, Craig, RB, Hernandez, C, Boccieri, ME, Firestine, A, Chun, KY, Long, MD & Kappelman, MD 2023, 'Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease', Inflammatory bowel diseases, vol. 29, no. 3, pp. 483-486. https://doi.org/10.1093/ibd/izac138

TY - JOUR

T1 - Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease

AU - Weaver, Kimberly N.

AU - Zhang, Xian

AU - Dai, Xiangfeng

AU - Chen, Wenli

AU - Watkins, Runa

AU - Adler, Jeremy

AU - Dubinsky, Marla C.

AU - Kastl, Arthur

AU - Bousvaros, Athos

AU - Strople, Jennifer A.

AU - Cross, Raymond K.

AU - Higgins, Peter D.R.

AU - Ungaro, Ryan C.

AU - Bewtra, Meenakshi

AU - Bellaguarda, Emanuelle

AU - Farraye, Francis A.

AU - Craig, Riley Bs

AU - Hernandez, Cristian

AU - Boccieri, Margie E.

AU - Firestine, Ann

AU - Chun, Kelly Y.

AU - Long, Millie D.

AU - Kappelman, Michael D.

PY - 2023/3/1

Y1 - 2023/3/1

N2 - We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.

AB - We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.

UR - http://www.scopus.com/inward/record.url?scp=85149172525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149172525&partnerID=8YFLogxK

U2 - 10.1093/ibd/izac138

DO - 10.1093/ibd/izac138

M3 - Article

C2 - 35830416

AN - SCOPUS:85149172525

SN - 1078-0998

VL - 29

SP - 483

EP - 486

JO - Inflammatory bowel diseases

JF - Inflammatory bowel diseases

IS - 3

ER -

Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this